Rui Gardner

9PUBLICATIONS
119CO-AUTHORS
Tumour immunologyMolecular targetsMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Software and application security
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.

Masataka Amisaki, Abderezak Zebboudj, Hiroshi Yano

|Dec 04, 2024
Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity.

Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu

|Aug 07, 2024
Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.

Victor Ng, Sonali Sinha, Ardijana Novaj

|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT.

Hana Andrlová, Oriana Miltiadous, Anastasia I Kousa

|Mar 02, 2022
Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.

Rodrigo Gularte-Mérida, Shaleigh Smith, Anita S Bowman

|Jul 02, 2021
Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.

Ricardo G Alvim, Petrina Georgala, Lucas Nogueira

Pageof 2

Frequent Collaborators

2 joint publications

Mithat Gönen

2 joint publications

Jorge S Reis-Filho

2 joint publications

Britta Weigelt

1 joint publications

Bartek Rajwa